RVPH

Q: What is the price of Reviva Pharmaceuticals (RVPH) today?

The price of Reviva Pharmaceuticals (RVPH) today is $ 0.67, with return of -74.51% compared to the last year. The price of Reviva Pharmaceuticals (RVPH) started the year trading around $ 1.81 and today it is at $ 0.67. Follow the real-time price chart, the historical price of Reviva Pharmaceuticals (RVPH) and international markets.

Q: When does Reviva Pharmaceuticals (RVPH) pay dividends?

Reviva Pharmaceuticals (RVPH) did not distribute dividends in the last year.

Q: Is Reviva Pharmaceuticals (RVPH) worth it?

Currently, Reviva Pharmaceuticals (RVPH) is priced at $ 0.67, with a P/E of -1.98%, representing a deviation of -329% from its historical average P/E. In the last year, the stock showed a variation of -74.51 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -74.51%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Reviva Pharmaceuticals (RVPH) stock?

Investing in stocks of Reviva Pharmaceuticals (RVPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Reviva Pharmaceuticals (RVPH) yield today?

The yield of Reviva Pharmaceuticals (RVPH) was 22.95% in the last month, -74.51% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Reviva Pharmaceuticals (RVPH) today, the total investment would be $ 66.53, based on the current price of $ 0.67.If past performance were to repeat, the return on your investment would be:In 1 year: $ 16.96In 5 years: $ 66.53In 10 years: $ 66.53It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Reviva Pharmaceuticals Holdings Inc.

Price

$ 0.67

return (12m)

-74.51%

p/e

-1.98

p/bv

9.88

DIVIDEND YIELD

0.00%

price RVPH

RVPH

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of RVPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

22.95%

3 months

50.42%

1 year

-74.51%

2 years

-82.49%

5 years

0.00%

10 years

0.00%

Fundamentals RVPH

review the fundamentals of Reviva Pharmaceuticals shares

P/E

-1.98

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

Sector: -3.71 Industry: -3.71

P/BV

9.88

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-158.76%

Sector: -63.91% Industry: -63.91%

ROE

-500.00%

Sector: -67.36% Industry: -67.36%

ROIC

-1,026.42%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

0.00%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

0.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

0.00%

Sector: -41.51% Industry: -41.51%

P/EBITDA

-1.98

Sector: -3.78 Industry: -3.78

P/EBIT

-1.98

Sector: -3.91 Industry: -3.91

P/ASSET

3.14

Sector: 1.49 Industry: 1.49

BVPS

0.06

Sector: 1.73 Industry: 1.73

EPS

-0.31

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.32

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

43.16%

Sector: - Industry: -

Fundamentals RVPH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.36	0.00	0.00%	2.52%	$ 486.25 B	27.26%
PFE	15.06	1.59	10.56%	6.61%	$ 147.98 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.76	6.09	20.45%	1.74%	$ 279.74 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.58	7.02	37.80%	2.59%	$ 150.68 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.44	14.70	118.17%	0.00%	$ 7.41 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	25.34	18.45	72.82%	2.85%	$ 177.48 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.65	11.00	48.57%	0.00%	$ 4.74 B	42.87%
BIIB	16.57	1.46	8.83%	0.00%	$ 26.65 B	15.98%
HRMY	12.44	2.77	22.24%	0.00%	$ 2.31 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RVPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings Inc.

Average user rating I10

4.0 (0 people)

United States

7 years

Founded: 2018

2020

Time since IPO - 5 years

5

Employees

The Company Reviva Pharmaceuticals Holdings Inc. (United States), is listed on Nasdaq with a market value of $ 44.98 Millions, having an equity of $ 4.55 Millions.

With a total of 5 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -22.75 Millions.

As for its main indicators, the Company has a P/E ratio of -1.98, a P/BV ratio of 9.88 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker RVPH.

Market cap

$ 44.98 Millions

Net worth

$ 4.55 Millions

US$ 4,550,000.00

Assets

$ 14.33 Millions

US$ 14,330,000.00

Total Shares Outstanding

73.00 Millions

73,000,000

Average Daily Trading Volume

$ 11.00 Millions

US$ 11,000,889.40

Sector

Health Care

Industry

Biotechnology

RVPH

RVPH revenue and profits

Financial Results RVPH

DRAG THE FRAME TO SEE MORE DATA

RVPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

19.36

2.52%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

15.06

6.61%

ROE

10.56%

P/BV

1.59

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.76

1.74%

ROE

20.45%

P/BV

6.09

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

19.36

2.52%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

15.06

6.61%

ROE

10.56%

P/VP

1.59

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.76

1.74%

ROE

20.45%

P/VP

6.09

Frequently Asked Questions

What is the price of Reviva Pharmaceuticals (RVPH) today?

The price of Reviva Pharmaceuticals (RVPH) today is $ 0.67, with return of -74.51% compared to the last year. The price of Reviva Pharmaceuticals (RVPH) started the year trading around $ 1.81 and today it is at $ 0.67. Follow the real-time price chart, the historical price of Reviva Pharmaceuticals (RVPH) and international markets.

When does Reviva Pharmaceuticals (RVPH) pay dividends?

Reviva Pharmaceuticals (RVPH) did not distribute dividends in the last year.

Is Reviva Pharmaceuticals (RVPH) worth it?

Currently, Reviva Pharmaceuticals (RVPH) is priced at $ 0.67, with a P/E of -1.98%, representing a deviation of -329% from its historical average P/E. In the last year, the stock showed a variation of -74.51 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -74.51%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Reviva Pharmaceuticals (RVPH) stock?

Investing in stocks of Reviva Pharmaceuticals (RVPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Reviva Pharmaceuticals (RVPH) yield today?

The yield of Reviva Pharmaceuticals (RVPH) was 22.95% in the last month, -74.51% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Reviva Pharmaceuticals (RVPH) today, the total investment would be $ 66.53, based on the current price of $ 0.67.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 16.96
In 5 years: $ 66.53
In 10 years: $ 66.53

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

RVPH

Reviva Pharmaceuticals Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of RVPH

review the fundamentals of Reviva Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings Inc.

United States

7 years

2020

5

PROFIT X PRICE RVPH

Financial Results RVPH

RVPH cash flow

asset growth - RVPH

RVPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions